RankAlpha logo
Back to Rankings

SRRK

Scholar RockD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
SRRK vs peer average
44/100
SRRK vs. peer average (D vs. D)
Grade spread
B 3 · C 1 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

REGN is the first available peer comparator.

Established biologics developer; useful comparator for regulatory/commercial execution and partnership outcomes.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerREGNRegeneron
SRRK
Scholar Rock
REGN
Regeneron
Grade
D
C
Momentum
69
70
Value
41
64
Sentiment
52
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed

Grade position vs REGN

SRRK / REGN
Grade Position
Below peers
SRRK vs. peer average (D vs. D)
44/100
Momentum
69
REGN
Value
41
REGN
Sentiment
52
REGN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SRRK
1
REGN
REGN
B
80/100
-2
2
AMGN
AMGN
D
40/100
Even
3
BIIB
BIIB
C
60/100
-1
4
ERAS
Erasca Inc Common
F
20/100
+1
5
BDRX
Biodexa Pharmaceuticals plc ADR
D
40/100
Even
REGN is the first peer returned for this comparison set.